October 28, 2022 03:12 PM EDTUpdated October 31, 04:52 AM
Pharma
Manufacturing

Up­dat­ed: A short­age of amox­i­cillin is now be­ing re­port­ed by sev­er­al man­u­fac­tur­ers

Tyler Patchen

News Reporter

On­ly a few weeks af­ter the FDA rec­og­nized a short­age of Adder­all, an­oth­er cru­cial drug is in low sup­ply, this time the an­tibi­ot­ic amox­i­cillin …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times